TY Howton
Directeur des opérations chez SOLID BIOSCIENCES INC.
Fortune : 65 621 $ au 30/04/2024
Profil
David Tyronne Howton is currently the Chief Operating Officer at Solid Biosciences, Inc. He previously held positions as Director at Make-A-Wish Foundation of Massachusetts, Chief Healthcare Compliance Officer at Genentech, Inc., Secretary, Chief Legal Officer & Senior VP at Vertex Pharmaceuticals, Inc., Secretary, Senior Vice President & General Counsel at Sarepta Therapeutics, Inc., and Chief Operating Officer & General Counsel at Aavantibio, Inc. He obtained his undergraduate degree from Yale University and his graduate degree from Northwestern University School of Law.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
SOLID BIOSCIENCES INC.
0,02% | 31/03/2024 | 7 684 ( 0,02% ) | 65 621 $ | 30/04/2024 |
Postes actifs de TY Howton
Sociétés | Poste | Début |
---|---|---|
SOLID BIOSCIENCES INC. | Directeur des opérations | 01/09/2023 |
Anciens postes connus de TY Howton
Sociétés | Poste | Fin |
---|---|---|
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | Directeur des opérations | 01/12/2022 |
SAREPTA THERAPEUTICS, INC. | Conseiller Juridique Général | - |
VERTEX PHARMACEUTICALS INCORPORATED | Conseiller Juridique Général | 12/06/2012 |
Make-A-Wish Foundation of Massachusetts | Directeur/Membre du Conseil | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Formation de TY Howton
Yale University | Undergraduate Degree |
Northwestern University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
SAREPTA THERAPEUTICS, INC. | Health Technology |
SOLID BIOSCIENCES INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | Health Technology |
Make-A-Wish Foundation of Massachusetts |